AlphaYouBA
Insider buying
Behzad Aghazadeh bought $36.3M of Scribe Therapeutics, Inc. (SCTX) stock
Behzad Aghazadeh, Dir, 10% of Scribe Therapeutics, Inc. (SCTX), bought 2,391,238 shares of SCTX stock worth $36.3M, per an SEC Form 4 filed Jul 29, 2026.
The shares came through a private deal, not the open market.
The trade happened on Jul 24, 2026, 5 days before it was made public.
SCTX has moved +29.6% since the trade date, from $21.65 to $28.05 (Sep 21, 2026 close).
- Traded
- Jul 24, 2026
- Disclosed
- Jul 29, 2026
- Filing delay
- 5 days
- Price since
- +29.6%
- Role
- Dir, 10%
- Source
- SEC Form 4
More SCTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.